Assessing Community and Healthcare Provider Preferences for Doxycycline as STI PrEP/PEP among 2S/GBTQ People in British Columbia

评估不列颠哥伦比亚省 2S/GBTQ 人群中社区和医疗保健提供者对强力霉素作为 STI PrEP/PEP 的偏好

• 批准号: 488756
• 负责人: Hull Mark W
• 金额: $ 7.29万
• 依托单位: Community-Based Research Centre (Vancouver B.C.)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2023
• 资助国家: 加拿大
• 起止时间: 2023-05-01 至 2024-05-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=488756&lang=en
• 关键词: 2sgbtq; Biomedical Prevention; Community-Based Research; Qualitative

Background: Two-Spirit, gay, bisexual, trans, and queer men and non-binary (2S/GBTQ) people have high rates of STBBIs in Canada. A common antibiotic called doxycycline may be an effective way to prevent some STBBIs that impact 2S/GBTQ people (doxy PrEP/PE

背景：在加拿大，双灵，同性恋，双性恋，跨性别和酷儿男性和非二元（2S/GBTQ）人群的STBBI率很高。一种名为强力霉素的常见抗生素可能是预防影响2S/GBTQ人群的一些STBBI的有效方法（doxy PrEP/PE